Passage Bio, INC. (PASG) SEC Filings — 2025

Filings

• Passage Bio Narrows Q3 Loss Amid R&D Cuts, Cash Position Improves — 10-Q · Nov 10, 2025
• Passage BIO Announces Board and Executive Changes — 8-K · Sep 18, 2025
• Passage Bio Narrows Losses, Boosts Cash Amid R&D Cuts — 10-Q · Aug 12, 2025
• Passage BIO, Inc. Files 8-K Report — 8-K · Jul 29, 2025
• Passage BIO, Inc. Files 8-K with Corporate Updates — 8-K · Jul 14, 2025
• Passage BIO Files 8-K — 8-K · Jun 23, 2025
• Passage BIO, Inc. Reports on Security Holder Vote — 8-K · May 30, 2025
• Passage BIO, Inc. Files Q1 2025 10-Q — 10-Q · May 13, 2025
• Passage BIO Files 2025 Proxy Statement — DEF 14A · Apr 16, 2025
• Passage BIO Files 2024 10-K — 10-K · Mar 4, 2025
• Passage BIO Faces Delisting Concerns — 8-K · Jan 31, 2025
• Passage BIO, Inc. Files 8-K on Operations and Disposals — 8-K · Jan 10, 2025